Question 1

What are the potential benefits of participating in this trial for my baby?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics clinical trial (NCT02527681). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ceftobiprole compare to other antibiotics that my baby might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics clinical trial (NCT02527681). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of if my baby participates?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics clinical trial (NCT02527681). Contact the study team or your healthcare provider for specific answers.

Question 4

How will you monitor my baby's health during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics clinical trial (NCT02527681). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my baby does not respond well to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics clinical trial (NCT02527681). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements for participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics clinical trial (NCT02527681). Contact the study team or your healthcare provider for specific answers.

What this study is about